newsfilter
← Latest News
GlobeNewswire·

Korro to Present at the 2026 Jefferies Global Healthcare Conference in London

  • Korro Bio, Inc. (Nasdaq: KRRO) announced that CEO Ram Aiyar will present at the 2026 Jefferies Global Healthcare Conference in London on November 16-19, 2026.
  • Dr. Aiyar's presentation is scheduled for Thursday, November 19, 2026, at 8:00 AM GMT (3:00 AM ET).
  • A live webcast of the event will be available on the "Events & Presentations" page of Korro's website at www.korrobio.com.
  • A replay of the presentation will be accessible for 90 days following the live event.
  • Korro utilizes its proprietary OPERA platform to develop genetic medicines that perform precise, tissue-directed RNA editing via RNA-editing oligonucleotides.
  • The company's approach aims to produce therapeutic proteins with augmented activity by modifying native mRNA transcripts rather than DNA.
  • Korro plans to leverage delivery modalities such as GalNAc conjugation for subcutaneous administration to advance its drug portfolio.
  • The company is based in Cambridge, Massachusetts, \& intends to disclose material nonpublic information via its Investor Relations website, LinkedIn, \& X (Twitter).
  • Investor \& media inquiries can be directed to Malini Chatterjee at Blueprint Life Science Group via email or phone at 917.330.4269.
Company
Korro Bio, Inc.
Keywords
Nasdaq:KRRO, Korro Bio, Inc.